Literature DB >> 39566

Limited plasmapheresis in rheumatoid arthritis with vasculitis.

J A Goldman, H L Casey, H McIlwain, J Kirby, C H Wilson, S B Miller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 39566     DOI: 10.1002/art.1780221019

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  8 in total

Review 1.  Rheumatoid Vasculitis: A Diminishing Yet Devastating Menace.

Authors:  Shweta Kishore; Lisa Maher; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

Review 2.  Optimisation of cyclophosphamide therapy in systemic vasculitis.

Authors:  R Richmond; T W McMillan; R A Luqmani
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

3.  Vasculitis associated with rheumatoid arthritis: a case-control study.

Authors:  Ashima Makol; Cynthia S Crowson; David A Wetter; Olayemi Sokumbi; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2014-01-17       Impact factor: 7.580

4.  Rheumatoid vasculitis.

Authors:  D G Scott; P A Bacon
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

5.  Rheumatoid vasculitis: diagnostic and therapeutic decisions.

Authors:  R S Panush; P Katz; S Longley; J Love; H Stanley
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

6.  Rheumatoid vasculitis of the colon presenting as pancolitis.

Authors:  R W Burt; M M Berenson; C O Samuelson; W J Cathey
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

7.  Correlation of antibody to rheumatoid arthritis associated nuclear antigen and immune complexes to disease activity in patients with rheumatoid arthritis.

Authors:  M A Alspaugh; D Rosenstock; J J Biundo; R C Gupta
Journal:  Clin Exp Immunol       Date:  1983-02       Impact factor: 4.330

Review 8.  Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease.

Authors:  R Luqmani; C Gordon; P Bacon
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.